validation study of the anti-fatigue effects of Salmon extra containing anserine for the person performing daily exercise

validation study of the anti-fatigue effects of Salmon extra containing anserine for the person performing daily exercise - the anti-fatigue effects of Salmon extra containing anserine

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022743

Enrollment

Registered

2016-07-19

Start date

2016-06-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

validation of the anti-fatigue effects

Interventions

Oral ingestion of the control product(2week) Oral ingestion of the test product(jelly containing anserine)(2week)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Continued tennis rally is more than 10 times

Exclusion criteria

Exclusion criteria: 1) Individuals judged inappropriate for the study by the principal 2) Individuals using medical products( sleeping drug) 3) Individuals who had a habit to ingest health foods or supplements(Sleep improvement functional food) 4) Individuals who are sensitive to test products 5) Individuals who have a history of serious hepatopathy, kidney damage, heart disease 6) Smoker

Design outcomes

Primary

Measure	Time frame
performance test (shot of tennis) 2week after	—

Secondary

Measure	Time frame
Obstructive Sleep Apnoea(OSA) POMS Pulse wave Heart rate amylase activating in saliva	—

Countries

Japan

Contacts

Public ContactTatsuya Konishi

Maruha Nichiro Corporation Central Research Institute

t-konishi@maruha-nichiro.co.jp029-864-6712

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026